Insights
Search Results
Client Highlights
4.14.26
Firm Advises Getlabs on Acquisition by Function
On April 8, 2026, Function Health announced it has acquired Getlabs, a leading mobile healthcare platform that brings licensed specialists directly to one's location. The acquisition allows for the continuation of Getlab’s nationwide network of providers, health systems, and partners, while advancing Function's broader commitment to making healthcare more accessible by building experiences around member needs. Wilson Sonsini Goodrich & Rosati advised Getlabs on the transaction.
Client Highlights
4.13.26
Wilson Sonsini Advises Elorian on $55 Million Seed Financing as Company Emerges from Stealth
On April 9, 2026, Palo Alto-based Elorian AI, a start-up building models for visual reasoning, emerged from stealth and announced a $55 million seed funding led by Striker Ventures, Menlo Ventures, and Altimeter. 49 Palms, prominent AI researchers, and other investors also participated in the round. Wilson Sonsini Goodrich & Rosati advised Elorian on the transaction.
Client Highlights
4.08.26
Wilson Sonsini Advises HexemBio on $10.4 Million Seed Round
On April 7, 2026, HexemBio announced its public launch as a biotechnology company developing the breakthrough blood stem cell rejuvenation therapy, alongside the close of a $10.4 million seed round. The round is led by Draper Associates with participation from SOSV, Seraphim, and other strategic investors. The funding will be used to finalize HexemBio’s IND-enabling studies and GMP manufacturing, with the company targeting first-in-human trials in 2027. Wilson Sonsini Goodrich & Rosati advised HexemBio on the transaction.
Client Highlights
1.28.26
Firm Advises Lead Investor G2 Venture Partners on Waabi’s $1 Billion Fundraise
On January 28, 2026, Waabi, the leader in Physical AI, announced it has closed its oversubscribed $750 million Series C financing round co-led by G2 Venture Partners and Khosla Ventures, and secured an additional milestone-based future investment from Uber to support a new partnership to deploy robotaxis powered by the Waabi Driver exclusively on the Uber platform. The funding, the largest fundraise in Canadian history, will fuel the continued advancement of Waabi’s Physical AI Platform, further accelerate the company’s commercial progress in autonomous trucking, and support Waabi’s expansion into robotaxis. Wilson Sonsini Goodrich & Rosati advised G2 Venture Partners on the transaction.
The Wilson Sonsini team that advised G2 Venture Partners included Danielle Naftulin, Madeleine Vella, Rodrigo Valle, and Tori Fong.
For more information, please see Waabi’s announcement.
The Wilson Sonsini team that advised G2 Venture Partners included Danielle Naftulin, Madeleine Vella, Rodrigo Valle, and Tori Fong.
For more information, please see Waabi’s announcement.
Client Highlights
11.03.25
Wilson Sonsini Advises Pear Suite on $7.6 Million Series A Funding
On October 14, 2025, Pear Suite, a digital health company empowering community health workers, announced that it has raised $7.6 million in Series A funding. The investment round is led by Rock Health Capital and Nexxus Holdings, with support from Mucker Capital, Enable Ventures, The SCAN Foundation, Acumen America, Impact Engine, and the California Health Care Foundation. Wilson Sonsini Goodrich & Rosati advised Pear Suite on the transaction.
Client Highlights
8.07.25
Wilson Sonsini Advises Apreo Health on Oversubscribed $130 Million Series B
On August 7, 2025, Apreo Health, a clinical-stage medical device company developing a novel treatment for severe emphysema, announced the closing of an oversubscribed $130 million Series B financing round. The financing was co-led by new investors Bain Capital Life Sciences and Norwest, with participation from new investors F-Prime and Intuitive Ventures. Returning investors Lightstone Ventures and Santé Ventures also participated in the round. Wilson Sonsini Goodrich & Rosati advised Apreo Health on the transaction.
Client Highlights
4.22.25
Wilson Sonsini Advises Trove on Acquisition of reverse.supply
On April 14, 2025, Trove, the leader in branded resale and customer trade-in, announced that it is advancing its European and global expansion by acquiring reverse.supply, a German-based leader in the European branded resale market. Wilson Sonsini Goodrich & Rosati advised Trove on the transaction, in collaboration with Noerr Partnerschaftsgesellschaft mbB.
This acquisition marks a major milestone in Trove’s international platform rollout, making branded resale even more accessible, scalable, and operationally seamless for brands across 30 countries. By combining Trove's established technology platform with reverse.supply's deep European expertise, Trove now offers the most comprehensive and scalable set of technology components for brands seeking to implement circular solutions in North America, Europe, and the UK.
The Wilson Sonsini team that advised Trove on the transaction includes Bob O’Connor, Melissa Wright, Ben Armuth, Tori Fong, and Karen Becker.
For more information, please see Trove’s press release.
This acquisition marks a major milestone in Trove’s international platform rollout, making branded resale even more accessible, scalable, and operationally seamless for brands across 30 countries. By combining Trove's established technology platform with reverse.supply's deep European expertise, Trove now offers the most comprehensive and scalable set of technology components for brands seeking to implement circular solutions in North America, Europe, and the UK.
The Wilson Sonsini team that advised Trove on the transaction includes Bob O’Connor, Melissa Wright, Ben Armuth, Tori Fong, and Karen Becker.
For more information, please see Trove’s press release.